Article

Imbalance between excitatory and inhibitory amino acids at spinal level is associated with maintenance of persistent pain-related behaviors

Institute for Biomedical Sciences of Pain, Capital Medical University, Beijing 100069, PR China.
Pharmacological Research (Impact Factor: 3.98). 06/2009; 59(5):290-9. DOI: 10.1016/j.phrs.2009.01.012
Source: PubMed

ABSTRACT Although the postsynaptic events responsible for development of pathological pain have been intensively studied, the relative contribution of presynaptic neurotransmitters to the whole process remains less elucidated. In the present investigation, we sought to measure temporal changes in spinal release of both excitatory amino acids (EAAs, glutamate and aspartate) and inhibitory amino acids (IAAs, glycine, ?-aminobutyric acid and taurine) in response to peripheral inflammatory pain state. The results showed that following peripheral chemical insult induced by subcutaneous bee venom (BV) injection, there was an initial, parallel increase in spinal release of both EAAs and IAAs, however, the balance between them was gradually disrupted when pain persisted longer, with EAAs remaining at higher level but IAAs at a level below the baseline. Moreover, the EAAs-IAAs imbalance at the spinal level was dependent upon the ongoing activity from the peripheral injury site. Intrathecal blockade of ionotropic (NMDA and non-NMDA) and metabotropic (mGluRI, II, III) glutamate receptors, respectively, resulted in a differential inhibition of BV-induced different types of pain (persistent nociception vs. hyperalgesia, or thermal vs. mechanical hyperalgesia), implicating that spinal antagonism of any specific glutamate receptor subtype fails to block all types of pain-related behaviors. This result provides a new line of evidence emphasizing an importance of restoration of EAAs-IAAs balance at the spinal level to prevent persistence or chronicity of pain.

Download full-text

Full-text

Available from: Ming-Gang Liu, Aug 28, 2015
0 Followers
 · 
277 Views
  • Source
    • "Inhibitory synaptic transmission in the ACC was reduced in neonatally ketamine-treated rats Our previous work has demonstrated the importance of the excitation-inhibition imbalance in maintaining pathological pain-evoked behavioral and synaptic dysfunctions (Yan et al., 2009; Gong et al., 2010). In the present study, we hypothesized that neonatal ketamine treatment may result in a similar imbalance between excitatory and inhibitory synaptic transmission in the ACC. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Ketamine, a dissociative anesthetic most commonly used in many pediatric procedures, has been reported in many animal studies to cause widespread neuroapoptosis in the neonatal brain after exposure in high doses and/or for prolonged period. This neurodegenerative change occurs most severely in the forebrain including the anterior cingulated cortex (ACC) that is an important brain structure for mediating a variety of cognitive functions. However, it is still unknown whether such apoptotic neurodegeneration early in life would subsequently impair the synaptic plasticity of the ACC later in life. In this study, we performed whole-cell patch-clamp recordings from the ACC brain slices of young adult rats to examine any alterations in long-term synaptic plasticity caused by neonatal ketamine exposure. Ketamine was administered at postnatal day 4-7 (subcutaneous injections, 20 mg/kg given six times, once every 2 h). At 3-4 weeks of age, long-term potentiation (LTP) was induced and recorded by monitoring excitatory postsynaptic currents from ACC slices. We found that the induction of LTP in the ACC was significantly reduced when compared to the control group. The LTP impairment was accompanied by an increase in the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated excitatory synaptic transmission and a decrease in GABA inhibitory synaptic transmission in neurons of the ACC. Thus, our present findings show that neonatal ketamine exposure causes a significant LTP impairment in the ACC. We suggest that the imbalanced synaptic transmission is likely to contribute to ketamine-induced LTP impairment in the ACC.
    Neuroscience 03/2014; DOI:10.1016/j.neuroscience.2014.03.029 · 3.33 Impact Factor
  • Source
    • "Subsequent to activation of primary sensory neurons, glutamate is released from primary afferent terminals in the spinal dorsal horn, and then ionotropic ligand-gated glutamate receptors and G-protein-coupled metabotropic glutamate receptors (mGluRs) are activated [25]. mGluR5, a subgroup of the mGluRs, is reported to be highly expressed and thus involved in nociceptive processing in the spinal dorsal horn [26-28]. Intrathecal (i.t.) administration of the mGluR1/5 agonist induced spontaneous nocifensive behavior as well as thermal hyperalgesia and allodynia in rats [29,30]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background In the orofacial region, limited information is available concerning pathological tongue pain, such as inflammatory pain or neuropathic pain occurring in the tongue. Here, we tried for the first time to establish a novel animal model of inflammatory tongue pain in rats and to investigate the roles of metabotropic glutamate receptor 5 (mGluR5)-extracellular signal-regulated kinase (ERK) signaling in this process. Methods Complete Freund’s adjuvant (CFA) was submucosally injected into the tongue to induce the inflammatory pain phenotype that was confirmed by behavioral testing. Expression of phosphorylated ERK (pERK) and mGluR5 in the trigeminal subnucleus caudalis (Vc) and upper cervical spinal cord (C1-C2) were detected with immunohistochemical staining and Western blotting. pERK inhibitor, a selective mGluR5 antagonist or agonist was continuously administered for 7 days via an intrathecal (i.t.) route. Local inflammatory responses were verified by tongue histology. Results Submucosal injection of CFA into the tongue produced a long-lasting mechanical allodynia and heat hyperalgesia at the inflamed site, concomitant with an increase in the pERK immunoreactivity in the Vc and C1-C2. The distribution of pERK-IR cells was laminar specific, ipsilaterally dominant, somatotopically relevant, and rostrocaudally restricted. Western blot analysis also showed an enhanced activation of ERK in the Vc and C1-C2 following CFA injection. Continuous i.t. administration of the pERK inhibitor and a selective mGluR5 antagonist significantly depressed the mechanical allodynia and heat hyperalgesia in the CFA-injected tongue. In addition, the number of pERK-IR cells in ipsilateral Vc and C1-C2 was also decreased by both drugs. Moreover, continuous i.t. administration of a selective mGluR5 agonist induced mechanical allodynia in naive rats. Conclusions The present study constructed a new animal model of inflammatory tongue pain in rodents, and demonstrated pivotal roles of the mGluR5-pERK signaling in the development of mechanical and heat hypersensitivity that evolved in the inflamed tongue. This tongue-inflamed model might be useful for future studies to further elucidate molecular and cellular mechanisms of pathological tongue pain such as burning mouth syndrome.
    Journal of Neuroinflammation 11/2012; 9(1):258. DOI:10.1186/1742-2094-9-258 · 4.90 Impact Factor
  • Source
    • "Although the spinal mechanisms of the MRPH induced by bee venom are not fully known yet due to its pharmacologically intractable features, we also worked out a working hypothesis for reference according to previous parallel studies with other pain-related behavioral and neuronal activities. As clearly shown in Fig. 6, group I of mGluRs was demonstrated experimentally to be involved in induction and maintenance of the MRPH, while other membrane receptors including iGluRs (NMDA and AMPA/KA), groups II and III of mGluRs and NK1 are not likely to be involved (Yan et al., 2009). Antagonism or inhibition of TRPV1 and VDCC were not effective in suppression as well as prevention of the MRPH (Li et al., 2004a,b; Chen, 2007, 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bee venom injection as a therapy, like many other complementary and alternative medicine approaches, has been used for thousands of years to attempt to alleviate a range of diseases including arthritis. More recently, additional theraupeutic goals have been added to the list of diseases making this a critical time to evaluate the evidence for the beneficial and adverse effects of bee venom injection. Although reports of pain reduction (analgesic and antinociceptive) and anti-inflammatory effects of bee venom injection are accumulating in the literature, it is common knowledge that bee venom stings are painful and produce inflammation. In addition, a significant number of studies have been performed in the past decade highlighting that injection of bee venom and components of bee venom produce significant signs of pain or nociception, inflammation and many effects at multiple levels of immediate, acute and prolonged pain processes. This report reviews the extensive new data regarding the deleterious effects of bee venom injection in people and animals, our current understanding of the responsible underlying mechanisms and critical venom components, and provides a critical evaluation of reports of the beneficial effects of bee venom injection in people and animals and the proposed underlying mechanisms. Although further studies are required to make firm conclusions, therapeutic bee venom injection may be beneficial for some patients, but may also be harmful. This report highlights key patterns of results, critical shortcomings, and essential areas requiring further study.
    Progress in Neurobiology 10/2010; 92(2):151-83. DOI:10.1016/j.pneurobio.2010.06.006 · 10.30 Impact Factor
Show more